News

BIAL will be presenting the ACTIVATE study, a Phase II trial evaluating the efficacy, safety, tolerability, pharmacodynamics, and pharmacokinetics of BIA 28-6156 in patients with Parkinson's disease ...
SES is an established platform with a proven track record of growing its service offering across traditional energy, with further opportunities within the broader O&G service value chain and adjacent ...
At the heart of Egypt’s presentation was the upcoming Grand Egyptian Museum (GEM), officially opening on July 3, 2025. The ...
PETAH TIKVA, Israel, May 30, 2025 /PRNewswire/ -- Isotopia Molecular Imaging, in partnership with Cardirad , proudly announces the launch of Isoprotrace —an advanced Gallium-68 Gozetotide preparation ...
The AI agents mark a significant milestone as a direct outcome of the Google Cloud C enter of E xcellence, powered by Infosys Topaz™. The initiative leverages the advanced AI capabilities of Infosys ...
Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY), a global leader in next-generation digital services and consulting, today announced the launch of Infosys Agentic AI Foundry, a comprehensive solution ...
Las autoridades de la Franja de Gaza, controladas por el Movimiento de Resistencia Islámica (Hamás), han cifrado este martes ...
El delegado de Urbanismo, Medio Ambiente y Movilidad, Borja Carabante, tiene "plena tranquilidad" con el desarrollo de la ...
El secretario de Estado de Seguridad Social y Pensiones, Borja Suárez, ha asegurado que es posible "sin excesivos problemas" ...
El cold brew no es una moda pasajera. Esta infusión de café en frío -más suave, menos ácida y sin el clásico amargor- ha ...
El Fondo de Apoyo a la Solvencia de Empresas Estratégicas (Fasee), gestionado por la Sociedad Estatal de Participaciones ...